Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RVMD
#513
Revolution Medicines, Inc. Common Stock
102.020
0
+0.79%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+0.79%
Mudança mensal
+3.01%
Mudança em 6 meses
+84.15%
Mudança anual
+84.15%
Fechamento anterior
101.220
0
Open
102.020
0
Bid
Ask
Low
102.020
0
High
102.020
0
Volume
349
Mercados
Ações
Cuidados de saúde
RVMD
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
73.38 M
74.19 M
90.49 M
164.69 M
185.91 M
198.17 M
—
Valuation ratios
Enterprise value
2.8 B
1.76 B
1.92 B
3.95 B
7.59 B
15.4 B
36.94 B
Price to earnings ratio
-0.09
-0.01
-7.45
-7.31
-12.22
-13.39
-39.32
Price to sales ratio
-0.22
-0.05
52.3
275.84
—
—
—
Price to cash flow ratio
-0.09
-0.01
8.25
9.11
13.16
16.87
48.17
Price to book ratio
-0.02
-0
2.7
1.75
3.24
9.28
12.02
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.19
-0.25
-0.31
-0.21
-0.23
-0.48
-0.48
Return on equity %
-0.23
-0.31
-0.36
-0.24
-0.26
-0.69
-0.65
Return on invested capital %
-316.06
-464.6
-568.67
-926.47
-1 008.11
-1 170.61
—
Gross margin %
100
100
100
100
—
—
400
Operating margin %
-257.54
-639.7
-730.01
-4 207.12
—
—
-155.81 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-251.63
-636.58
-702.95
-3 768.28
—
—
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
9.63
9.77
10.65
13.06
14.2
7.14
40.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.05
0.05
0.01
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
424.34
2 455.33
-2.78
-3.1
-3.32
-4.72
-4.75
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
-1 869.05
-9 626.71
8
16.38
13.65
10.65
43.37
Net current asset value per share
-1 925.8
-9 838.9
8.19
16.61
13.88
10.91
44.25
Tangible book value per share
-1 692.56
-8 809.77
7.59
15.5
13.08
8.21
36.46
Working capital per share
-1 725.74
-8 832.11
7.42
15.34
12.9
9.39
39.6
Book value per share
-2 012.96
-10.05 K
8.5
16.14
13.5
8.58
37.96
Notícias
UBS inicia cobertura da Revolution com recomendação de compra
UBS assumes coverage on Revolution stock with buy rating on RAS inhibitor potential
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
Piper Sandler eleva preço-alvo das ações da Revolution com base em confiança no medicamento
Piper Sandler raises Revolution stock price target on drug confidence
Needham reduz preço-alvo das ações da Revolution para US$ 145 devido a custos mais altos
Needham lowers Revolution stock price target to $145 on higher costs
Wells Fargo eleva preço-alvo da Revolution Medicines com avanço em testes
Wells Fargo raises Revolution stock price target on trial progress
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript
Revolution Medicines in spotlight as earnings loom after M&A chatter
BB Biotech apresenta lucro 660% maior em 2025, mas projeta cautela para 2026